THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Julia Busik to Animals

Back to Details
This is a "connection" page, showing publications Julia Busik has written about Animals.
Julia Busik
Connection Strength
1.491
Animals
  1. Diabetic retinopathy is a ceramidopathy reversible by anti-ceramide immunotherapy. Cell Metab. 2024 Jul 02; 36(7):1521-1533.e5.
    View in: PubMed
    Score: 0.088
  2. Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy. Diabetologia. 2023 09; 66(9):1705-1718.
    View in: PubMed
    Score: 0.083
  3. Diabetes Retinopathy: New Ways to Detect and Treat. Methods Mol Biol. 2023; 2592:89-100.
    View in: PubMed
    Score: 0.080
  4. Untargeted Analysis of Lipids Containing Very Long Chain Fatty Acids in Retina and Retinal Tight Junctions. Methods Mol Biol. 2023; 2625:269-290.
    View in: PubMed
    Score: 0.080
  5. Fasting and fasting-mimicking treatment activate SIRT1/LXRa and alleviate diabetes-induced systemic and microvascular dysfunction. Diabetologia. 2021 07; 64(7):1674-1689.
    View in: PubMed
    Score: 0.071
  6. Extracellular Vesicle-Induced Classical Complement Activation Leads to Retinal Endothelial Cell Damage via MAC Deposition. Int J Mol Sci. 2020 Mar 01; 21(5).
    View in: PubMed
    Score: 0.066
  7. Plasma Exosomes Contribute to Microvascular Damage in Diabetic Retinopathy by Activating the Classical Complement Pathway. Diabetes. 2018 08; 67(8):1639-1649.
    View in: PubMed
    Score: 0.058
  8. ELOVL4-Mediated Production of Very Long-Chain Ceramides Stabilizes Tight Junctions and Prevents Diabetes-Induced Retinal Vascular Permeability. Diabetes. 2018 04; 67(4):769-781.
    View in: PubMed
    Score: 0.057
  9. Dual Anti-Inflammatory and Anti-Angiogenic Action of miR-15a in Diabetic Retinopathy. EBioMedicine. 2016 Sep; 11:138-150.
    View in: PubMed
    Score: 0.051
  10. Imbalances in Mobilization and Activation of Pro-Inflammatory and Vascular Reparative Bone Marrow-Derived Cells in Diabetic Retinopathy. PLoS One. 2016; 11(1):e0146829.
    View in: PubMed
    Score: 0.049
  11. Role of Acid Sphingomyelinase in Shifting the Balance Between Proinflammatory and Reparative Bone Marrow Cells in Diabetic Retinopathy. Stem Cells. 2016 Apr; 34(4):972-83.
    View in: PubMed
    Score: 0.049
  12. Wnting out ocular neovascularization: using nanoparticle delivery of very-low density lipoprotein receptor extracellular domain as Wnt pathway inhibitor in the retina. Arterioscler Thromb Vasc Biol. 2015 May; 35(5):1046-7.
    View in: PubMed
    Score: 0.047
  13. Regulation of retinal inflammation by rhythmic expression of MiR-146a in diabetic retina. Invest Ophthalmol Vis Sci. 2014 May 27; 55(6):3986-94.
    View in: PubMed
    Score: 0.044
  14. Changes in the daily rhythm of lipid metabolism in the diabetic retina. PLoS One. 2014; 9(4):e95028.
    View in: PubMed
    Score: 0.044
  15. Aldose reductase meets histone acetylation: a new role for an old player. Diabetes. 2014 Feb; 63(2):402-4.
    View in: PubMed
    Score: 0.043
  16. N-3 polyunsaturated Fatty acids prevent diabetic retinopathy by inhibition of retinal vascular damage and enhanced endothelial progenitor cell reparative function. PLoS One. 2013; 8(1):e55177.
    View in: PubMed
    Score: 0.040
  17. The unconventional role of acid sphingomyelinase in regulation of retinal microangiopathy in diabetic human and animal models. Diabetes. 2011 Sep; 60(9):2370-8.
    View in: PubMed
    Score: 0.036
  18. Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock. J Exp Med. 2009 Dec 21; 206(13):2897-906.
    View in: PubMed
    Score: 0.032
  19. Remodeling of retinal Fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4. Diabetes. 2010 Jan; 59(1):219-27.
    View in: PubMed
    Score: 0.032
  20. Global analysis of retina lipids by complementary precursor ion and neutral loss mode tandem mass spectrometry. Methods Mol Biol. 2009; 579:33-70.
    View in: PubMed
    Score: 0.030
  21. Intravitreal Administration of AAV2-SIRT1 Reverses Diabetic Retinopathy in a Mouse Model of Type 2 Diabetes. Transl Vis Sci Technol. 2023 04 03; 12(4):20.
    View in: PubMed
    Score: 0.020
  22. 2-Hydroxypropyl-?-cyclodextrin mitigates pathological changes in a mouse model of retinal cholesterol dyshomeostasis. J Lipid Res. 2023 02; 64(2):100323.
    View in: PubMed
    Score: 0.020
  23. Selective LXR agonist DMHCA corrects retinal and bone marrow dysfunction in type 2 diabetes. JCI Insight. 2020 07 09; 5(13).
    View in: PubMed
    Score: 0.017
  24. Mitochondrial Ceramide Effects on the Retinal Pigment Epithelium in Diabetes. Int J Mol Sci. 2020 May 28; 21(11).
    View in: PubMed
    Score: 0.017
  25. Diurnal Rhythmicity of Autophagy Is Impaired in the Diabetic Retina. Cells. 2020 04 07; 9(4).
    View in: PubMed
    Score: 0.017
  26. Retinal Vascular Abnormalities and Microglia Activation in Mice with Deficiency in Cytochrome P450 46A1-Mediated Cholesterol Removal. Am J Pathol. 2019 02; 189(2):405-425.
    View in: PubMed
    Score: 0.015
  27. Differential composition of DHA and very-long-chain PUFAs in rod and cone photoreceptors. J Lipid Res. 2018 09; 59(9):1586-1596.
    View in: PubMed
    Score: 0.015
  28. Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in db/db Mice. Diabetes. 2018 09; 67(9):1867-1879.
    View in: PubMed
    Score: 0.014
  29. Enteral Arg-Gln Dipeptide Administration Increases Retinal Docosahexaenoic Acid and Neuroprotectin D1 in a Murine Model of Retinopathy of Prematurity. Invest Ophthalmol Vis Sci. 2018 02 01; 59(2):858-869.
    View in: PubMed
    Score: 0.014
  30. Models of retinal diseases and their applicability in drug discovery. Expert Opin Drug Discov. 2018 04; 13(4):359-377.
    View in: PubMed
    Score: 0.014
  31. Come to the Light Side: In Vivo Monitoring of Pseudomonas aeruginosa Biofilm Infections in Chronic Wounds in a Diabetic Hairless Murine Model. J Vis Exp. 2017 10 10; (128).
    View in: PubMed
    Score: 0.014
  32. The Mechanism of Diabetic Retinopathy Pathogenesis Unifying Key Lipid Regulators, Sirtuin 1 and Liver X Receptor. EBioMedicine. 2017 Aug; 22:181-190.
    View in: PubMed
    Score: 0.014
  33. A bioluminescent Pseudomonas aeruginosa wound model reveals increased mortality of type 1 diabetic mice to biofilm infection. J Wound Care. 2017 Jul 01; 26(Sup7):S24-S33.
    View in: PubMed
    Score: 0.014
  34. Tumor Necrosis Factor Alpha (TNF-a) Disrupts Kir4.1 Channel Expression Resulting in M?ller Cell Dysfunction in the Retina. Invest Ophthalmol Vis Sci. 2017 05 01; 58(5):2473-2482.
    View in: PubMed
    Score: 0.014
  35. Conditional Deletion of Bmal1 Accentuates Microvascular and Macrovascular Injury. Am J Pathol. 2017 Jun; 187(6):1426-1435.
    View in: PubMed
    Score: 0.013
  36. Effects of GABA on spontaneous [Ca2+]c dynamics and electrical properties of rat adrenal chromaffin cells. Brain Res. 1996 Nov 11; 739(1-2):97-103.
    View in: PubMed
    Score: 0.013
  37. Ataxia Telangiectasia Mutated Dysregulation Results in Diabetic Retinopathy. Stem Cells. 2016 Feb; 34(2):405-17.
    View in: PubMed
    Score: 0.012
  38. A monophasic extraction strategy for the simultaneous lipidome analysis of polar and nonpolar retina lipids. J Lipid Res. 2014 Aug; 55(8):1797-809.
    View in: PubMed
    Score: 0.011
  39. Effect of reduced retinal VLC-PUFA on rod and cone photoreceptors. Invest Ophthalmol Vis Sci. 2014 Apr 10; 55(5):3150-7.
    View in: PubMed
    Score: 0.011
  40. Inhibition by a receptor-mediated Ca2+ entry blocker, SK&F 96365, of Ca2+ and secretory responses in rat pancreatic acini. Eur J Pharmacol. 1993 Nov 15; 247(3):273-81.
    View in: PubMed
    Score: 0.011
  41. Dicer expression exhibits a tissue-specific diurnal pattern that is lost during aging and in diabetes. PLoS One. 2013; 8(11):e80029.
    View in: PubMed
    Score: 0.011
  42. CNS inflammation and bone marrow neuropathy in type 1 diabetes. Am J Pathol. 2013 Nov; 183(5):1608-20.
    View in: PubMed
    Score: 0.011
  43. Per2 mutation recapitulates the vascular phenotype of diabetes in the retina and bone marrow. Diabetes. 2013 Jan; 62(1):273-82.
    View in: PubMed
    Score: 0.010
  44. Evaluation of sex-specific gene expression in archived dried blood spots (DBS). Int J Mol Sci. 2012; 13(8):9599-9608.
    View in: PubMed
    Score: 0.010
  45. Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase). Invest Ophthalmol Vis Sci. 2011 Oct 21; 52(11):8278-86.
    View in: PubMed
    Score: 0.009
  46. Non-mammalian fat-1 gene prevents neoplasia when introduced to a mouse hepatocarcinogenesis model: Omega-3 fatty acids prevent liver neoplasia. Biochim Biophys Acta. 2010 Oct; 1801(10):1133-44.
    View in: PubMed
    Score: 0.008
  47. Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation. Circ Res. 2009 Oct 23; 105(9):897-905.
    View in: PubMed
    Score: 0.008
  48. Complementary precursor ion and neutral loss scan mode tandem mass spectrometry for the analysis of glycerophosphatidylethanolamine lipids from whole rat retina. Anal Bioanal Chem. 2009 May; 394(1):267-75.
    View in: PubMed
    Score: 0.008
  49. Novel mechanism for obesity-induced colon cancer progression. Carcinogenesis. 2009 Apr; 30(4):690-7.
    View in: PubMed
    Score: 0.008
  50. Differential regulation of high glucose-induced glyceraldehyde-3-phosphate dehydrogenase nuclear accumulation in M?ller cells by IL-1beta and IL-6. Invest Ophthalmol Vis Sci. 2009 Apr; 50(4):1920-8.
    View in: PubMed
    Score: 0.008
  51. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J Lipid Res. 2006 Sep; 47(9):2028-41.
    View in: PubMed
    Score: 0.006
  52. Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases. J Lipid Res. 2005 Apr; 46(4):706-15.
    View in: PubMed
    Score: 0.006
  53. Regulation of hepatic GLUT8 expression in normal and diabetic models. Endocrinology. 2003 May; 144(5):1703-11.
    View in: PubMed
    Score: 0.005
  54. Exocytosis in the dissociated pancreatic acinar cells of the guinea pig directly visualized by VEC-DIC microscopy. Biochem Biophys Res Commun. 2000 Oct 14; 277(1):134-7.
    View in: PubMed
    Score: 0.004
  55. Glucose transporters control gene expression of aldose reductase, PKCalpha, and GLUT1 in mesangial cells in vitro. Am J Physiol. 1999 07; 277(1):F97-104.
    View in: PubMed
    Score: 0.004
  56. Competitive inhibition by procaine of carbachol-induced stimulus-secretion coupling in rat pancreatic acini. Br J Pharmacol. 1993 Oct; 110(2):603-8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES